| Metric | შპს ინოთიმი | შპს ჯი-ი-ეს-ეი ფარმაცევტიკალს |
|---|---|---|
| Growth | ||
| Revenue | ₾6.0m₾6.5m | ₾5.7m₾5.5m |
| Revenue growth | -8.8% | 2.4% |
| Profitability | ||
| EBITDA | ₾3.0m₾3.9m | ₾2.7m₾1.7m |
| EBITDA margin | 50.1%60.0% | 48.4%30.1% |
| Net profit | ₾2.6m₾3.3m | ₾2.6m₾1.6m |
| Net margin | 44.4%50.5% | 46.4%29.8% |
| Balance sheet | ||
| Total assets | ₾7.7m₾6.2m | ₾13.5m₾10.6m |
| Total equity | ₾7.7m₾6.2m | ₾11.7m₾9.1m |
| ROE | 34.2%53.4% | 22.4%18.1% |